10.06.2011 • NewsDIDPGlaxoSmithKline (GSK)GSK

Hong Kong Orders GSK To Recall Antibiotic Due to Plasticizer

Hong Kong has ordered GlaxoSmithKline(GSK) to recall an pediatric antibiotic manufactured in France over the presence of a plasticizer in the product, raising safety and quality concerns.       

The Department of Health said in a statement that diisodecyl phthalate (DIDP) was detected in GSK's Augmentin powder for syrup 156mg/5ml, a product for children.  A government laboratory test detected the presence of DIDP was two times higher than Europe's specific migration limit for food contact materials.

DIDP's safety for human consumption was not well established, but data from animal studies suggested long-term consumption of high levels of DIDP may affect the liver, the government said.      

The government said it had stepped up surveillance of pharmaceutical products containing flavoring agents after  Chinese media reports that Chinese importers had recalled bottled beverages from Taiwan that were suspected of being contaminated with a cancer-causing plastic additive.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.